JP2007099625A - Skin fibroblast growth promoter - Google Patents

Skin fibroblast growth promoter Download PDF

Info

Publication number
JP2007099625A
JP2007099625A JP2005287782A JP2005287782A JP2007099625A JP 2007099625 A JP2007099625 A JP 2007099625A JP 2005287782 A JP2005287782 A JP 2005287782A JP 2005287782 A JP2005287782 A JP 2005287782A JP 2007099625 A JP2007099625 A JP 2007099625A
Authority
JP
Japan
Prior art keywords
skin
moon peach
extract
fermented
fibroblast growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2005287782A
Other languages
Japanese (ja)
Other versions
JP4942322B2 (en
Inventor
Yoko Fujiwara
葉子 藤原
Morio Inafuku
盛雄 稲福
Sunao Inafuku
直 稲福
Tetsuya Fujino
哲也 藤野
Megumi Yonaha
恵 与那覇
Megumi Higa
めぐみ 比嘉
Yosuke Seyama
洋右 脊山
Yumi Aoki
由美 青木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ryukyu Bio Resource Development Co Ltd
Original Assignee
Ryukyu Bio Resource Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ryukyu Bio Resource Development Co Ltd filed Critical Ryukyu Bio Resource Development Co Ltd
Priority to JP2005287782A priority Critical patent/JP4942322B2/en
Publication of JP2007099625A publication Critical patent/JP2007099625A/en
Application granted granted Critical
Publication of JP4942322B2 publication Critical patent/JP4942322B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

<P>PROBLEM TO BE SOLVED: To obtain a safe skin fibroblast growth promoter that is useful for wrinkle measure regarded to be largest worries with respect to beautification, increases water holding property and keeps skin firmness and moisture, a skin care food and beverage and a skin care cosmetic containing the skin fibroblast growth promoter. <P>SOLUTION: The skin fibroblast growth promoter comprises an extract of a fermented substance, obtained by fermenting dried leaves of Alpinia speciosa with mixed bacteria of Lactobacillus plantrum, Streptococcus thermophilus and Bacillus subtilis, with hot water or 80% ethanol or the freeze-dried substance of them as an active ingredient. <P>COPYRIGHT: (C)2007,JPO&INPIT

Description

本発明は、月桃の発酵処理物を有効成分とする皮膚線維芽細胞増殖促進剤や、該皮膚線維芽細胞増殖促進剤を含有するスキンケア飲食品及びスキンケア化粧料に関する。   The present invention relates to a dermal fibroblast proliferation promoter containing a processed product of moon peach as an active ingredient, and a skin care food and drink and a skin care cosmetic containing the dermal fibroblast proliferation promoter.

表皮を構成する基底層には、メラニン色素を合成するメラノサイト(色素細胞)が存在し、メラニンの合成はメラノサイト内にできるメラノソームと呼ばれる単位膜に囲まれた小顆粒中で合成される。その過程は、アミノ酸の1種であるチロシンを出発物質としてチロシナーゼという酵素によってドーパ、さらにドーパキノンへ酸化される反応によって合成が開始される。メラニン合成に関与する酵素は、他に2種のチロシナーゼ関連蛋白が知られている。この経路で合成されるメラニンは茶〜黒色のユーメラニンと呼ばれ、ヒトにおいては皮膚、粘膜、毛髪のメラノサイトで合成される(例えば、非特許文献1参照)。メラノサイトの数は個人差があり、同一人においては部位によって異なっており、概して被覆部は少なく、露出部は多い。紫外線の照射を受けると、チロシナーゼ活性の増加をはじめとするメラニン合成が高まるとともに、メラノサイトの数も増加する。メラニンの沈着によって生じる様々なタイプの色素班があり、しみ、ソバカス、老人性色素班が代表的なものである。これらはいずれも紫外線が直接の原因であったり、増悪因子となることから美白剤とともに紫外線防御が有効なスキンケアとなるといわれている(例えば、非特許文献2参照)。   In the basal layer constituting the epidermis, melanocytes (pigment cells) that synthesize melanin exist, and the synthesis of melanin is synthesized in small granules surrounded by unit films called melanosomes formed in melanocytes. In this process, synthesis is initiated by a reaction in which tyrosine, which is one of amino acids, is oxidized to dopa and further to dopaquinone by an enzyme called tyrosinase. Two other tyrosinase-related proteins are known as enzymes involved in melanin synthesis. Melanin synthesized by this route is called brown to black eumelanin, and in humans, it is synthesized by skin, mucous membrane, and hair melanocytes (see, for example, Non-Patent Document 1). The number of melanocytes varies from person to person, and varies from site to site in the same person. Generally, there are few covered parts and many exposed parts. When irradiated with ultraviolet rays, melanin synthesis including an increase in tyrosinase activity increases, and the number of melanocytes also increases. There are various types of pigmentation caused by melanin deposition, with spots, freckles and senile pigmentation being typical. All of these are said to be skin care in which UV protection is effective together with a whitening agent since UV is a direct cause or an exacerbation factor (see, for example, Non-Patent Document 2).

従来より、上記機構によるメラニンの生成を防止するため、チロシナーゼの作用を阻害することができる種々の物質が化粧品や食品の分野で使われ、その代表的なものはアスコルビン酸、硫黄類、ハイドロキノン、コウジ酸、アルブチン、天然の植物抽出物等である。これまでにも幾つかの天然の植物抽出物が試みられた。例えば、グアバ(Psidium guajava L.)又はエリカ(Erica)を抽出処理して得られた抽出物を有効成分とするチロシナーゼ阻害剤、これを含む美白化粧品(例えば、特許文献1参照)や、水及び/又は有機溶媒を使用して抽出したチロシナーゼの阻害活性を有する葡萄の種の抽出物、これを含む美白機能等を有する化粧品または食品(例えば、特許文献2参照)や、発芽玄米の、水及び/又は有機溶媒の抽出物を有効成分として含有してなるチロシナーゼ阻害剤、及び美白用機能性食品(例えば、特許文献3参照)や、チロシナーゼ抑制物質として甘草エキス、プラセンタエキス、麹酸等から選ばれる少なくとも1種と、白樺エキス及び還元物質を含有する美白組成物(例えば、特許文献4参照)や、Hibiscus syriacus L. 抽出物を含有するメラニン生成抑制剤、該抑制剤を化粧品や食品に配合して用いること(例えば、特許文献5参照)や、ヤナギタデ抽出物を有効成分とするチロシナーゼ阻害剤、これを含有する美白剤及び美白用飲食品(例えば、特許文献6参照)が知られている。   Conventionally, various substances capable of inhibiting the action of tyrosinase have been used in the field of cosmetics and foods in order to prevent the production of melanin by the above mechanism, and representative examples thereof include ascorbic acid, sulfurs, hydroquinone, Kojic acid, arbutin, natural plant extracts and the like. Some natural plant extracts have been tried so far. For example, a tyrosinase inhibitor containing, as an active ingredient, an extract obtained by extracting guava (Psidium guajava L.) or Erica (Erica), whitening cosmetics containing the same (for example, see Patent Document 1), water and And / or an extract of camellia seeds having an inhibitory activity on tyrosinase extracted using an organic solvent, a cosmetic or food product having a whitening function or the like containing the same, water of germinated brown rice, and water And / or a tyrosinase inhibitor containing an organic solvent extract as an active ingredient, and a functional food for whitening (see, for example, Patent Document 3), and a tyrosinase inhibitory substance selected from licorice extract, placenta extract, oxalic acid, and the like A whitening composition containing white birch extract and a reducing substance (see, for example, Patent Document 4) and a melanin inhibitor containing Hibiscus syriacus L. extract A pharmaceutical preparation, use of the inhibitor in cosmetics and foods (see, for example, Patent Document 5), a tyrosinase inhibitor containing a Yanagita extract as an active ingredient, a whitening agent and a whitening food and drink containing the same ( For example, see Patent Document 6).

他方、月桃(Alpinia Speciosa K. Schum)はショウガ科(Zingiberaceae)に属し、別名アルピニアといい、九州南部から中国南部〜熱帯アジアに分布し、葉に芳香があるので食物を包み,葉鞘は網や綱の原料として利用されている。月桃を利用したスキンケアに関連したものとしては、月桃に含まれるカワイン類、ポリフェノール(クエルセチン)類、葉緑素などが、活性酸素や紫外線などの皮膚への悪影響を抑制し、メラニン色素の沈着を抑える機能を発揮することによる優れた美白効果などを備え、かつ、防腐剤などを添加しなくても腐敗しにくい安全性の高いパック剤を提供するため、月桃の葉及び/又は茎を乾燥する乾燥工程と、乾燥した前記月桃の葉及び/又は茎を粉砕して、平均粒径が10〜50μmの月桃粉末とする粉砕工程と、粉砕された前記月桃粉末とジェル化剤とを混合してジェル化するジェル化工程とを具備することを特徴とするパック剤の製造方法(例えば、特許文献7参照)や、ローズマリー、またはペパーミント、またはカモミール、またはローズゼラニウム、またはラベンダー、またはレモングラス、または月桃類のハーブのうち、少なくとも一種類のハーブを灰にしたものが石けん素地に配合されることを特徴とする美容石けん(例えば、特許文献8参照)や、葉エキスと、鶏冠抽出物と、米抽出物と、ヘマトコッカス藻抽出物と、フェヌグリークエキスと、バラ花びらエキスと、黒こしょうエキスとを含有させたことを特徴とする美肌促進剤(例えば、特許文献9参照)が知られている。   On the other hand, moon peach (Alpinia Speciosa K. Schum) belongs to the family Zingiberaceae, also known as Alpinia. It is distributed from southern Kyushu to southern China to tropical Asia. It is used as a raw material for and ropes. As for skin care using moon peaches, cautains, polyphenols (quercetin), and chlorophyll contained in moon peaches suppress adverse effects on the skin such as active oxygen and ultraviolet rays, and reduce melanin pigment deposition. Drying the leaves and / or stems of moon peaches to provide a highly safe pack that has excellent whitening effect due to its suppressive function and is resistant to spoilage without the addition of preservatives. A drying step, a pulverizing step of pulverizing the dried moon peach leaves and / or stems to obtain a moon peach powder having an average particle size of 10 to 50 μm, and the pulverized moon peach powder and a gelling agent And a gelling step of mixing into a gel to produce a pack (see, for example, Patent Document 7), rosemary, peppermint, chamomile, or ro Cosmetic soap characterized in that at least one herb made of ash, which is made of zugeronium, lavender, lemongrass, or moon peach, is blended in a soap base (see, for example, Patent Document 8) ), Leaf extract, chicken crown extract, rice extract, hematococcus algae extract, fenugreek extract, rose petal extract, and black pepper extract, For example, see Patent Document 9).

さらに、グアバの葉や月桃,ヨモギ,茶葉等の植物資源を細かく粉砕し、これに培養基としてストレプトコッカッス・サーモフィラス、ラクトバチルス・プランタリウム及びバチルス・サブティリスの三種類の乳酸菌、及び酵母菌を加え、さらに糖蜜、水分を加えて数日間発酵して得られる、血圧上昇の抑制作用の向上が期待される、発酵食材(例えば、特許文献10参照)が本出願人により提案されている。   Furthermore, plant resources such as guava leaves, moon peaches, mugworts, tea leaves, etc. are finely crushed, and as a culture medium, three types of lactic acid bacteria, Streptococcus thermophilus, Lactobacillus plantarium and Bacillus subtilis, and yeast In addition, fermented foods (see, for example, Patent Document 10), which are obtained by adding molasses and water and fermenting for several days and are expected to improve blood pressure increase, have been proposed by the present applicant.

また、皮膚線維芽細胞の増殖は種々の細胞成長因子によって複雑に制御されていることが知られている。その主要なものは、血小板由来成長因子(PDGF)、塩基性線維芽細胞成長因子(b−FGF)、形質転換成長因子−β(TGF−β)、結合組織成長因子(CTGF)などであり、これらの成長因子は、皮膚線維芽細胞の増殖制御以外にも多様な生理活性を有しており、創傷治癒や疾患の発生に関与している。例えば、PDGFやCTGFは皮膚線維芽細胞の走化性を、b−FGFは血管新生を、TGF−βはマトリックスタンパクの合成を促進する。そして、皮膚線維芽細胞は、コラーゲンやエラスチンといった肌の保水性を保つために必要な成分を作り出しており、年とともに線維芽細胞の数が減ると保水性が保てずはりがなくなり、しわなどが増えてくるといわれている。ビタミンCは、真皮層に浸透して線維芽細胞を活性化して、コラーゲンを生成し、しわ対策に有効で肌再生作用を有するといわれている。また、肌再生作用を有する女性ホルモンは、線維芽細胞に働きかけ、ヒアルロン酸やコラーゲンの合成を活性化し、同様にイソフラボンも真皮層のコラーゲンの代謝活性を向上して、肌に張りを持たせる作用が期待されている。   In addition, it is known that the proliferation of dermal fibroblasts is complicatedly controlled by various cell growth factors. The main ones are platelet derived growth factor (PDGF), basic fibroblast growth factor (b-FGF), transforming growth factor-β (TGF-β), connective tissue growth factor (CTGF), etc. These growth factors have various physiological activities in addition to the control of dermal fibroblast proliferation, and are involved in wound healing and disease development. For example, PDGF and CTGF promote chemotaxis of dermal fibroblasts, b-FGF promotes angiogenesis, and TGF-β promotes matrix protein synthesis. Skin fibroblasts produce the necessary ingredients to maintain skin water retention, such as collagen and elastin. If the number of fibroblasts decreases with age, the water retention cannot be maintained and wrinkles are lost. It is said that will increase. Vitamin C is said to penetrate the dermis layer and activate fibroblasts to produce collagen, which is effective in combating wrinkles and has a skin regeneration action. In addition, female hormones that have a skin regeneration action act on fibroblasts to activate the synthesis of hyaluronic acid and collagen, and isoflavones also improve the metabolic activity of collagen in the dermis layer and give skin tension. Is expected.

特開平6−305978号公報JP-A-6-305978 特開2000−159681号公報JP 2000-159681 A 特開2001−240556号公報JP 2001-240556 A 特開2001−335498号公報JP 2001-335498 A 特開2003−171300号公報JP 2003-171300 A 特開2004−83488号公報JP 2004-83488 A 特開2005−60260号公報Japanese Patent Laid-Open No. 2005-60260 特開2003−55697号公報JP 2003-55697 A 特開2005−47860号公報JP-A-2005-47860 特開2002−330725号公報JP 2002-330725 A 光井武夫編「新化粧品学」第14〜16頁、2002年3月25日、株式会社南山堂発行Published by Takeo Mitsui, “New Cosmetics”, pp. 14-16, March 25, 2002, published by Nanzan-do Co., Ltd. 光井武夫編「新化粧品学」第26〜28頁、2002年3月25日、株式会社南山堂発行Published by Takeo Mitsui, “New Cosmetics”, pp. 26-28, March 25, 2002, published by Nanzan-do Co., Ltd.

スキンケアや皮膚の老化を考える上で、皮膚線維芽細胞の増殖制御は重要であるとされている。皮膚線維芽細胞の増殖や機能を制御することにより、皮膚の老化を防ぎ、何時までも若々しい皮膚を維持することができる可能性がある。本発明の課題は、美容上もっとも多い悩みとされるしわ対策に有用であり、保水性を高めて肌のはりや潤いを保つことが可能となる、安全な皮膚線維芽細胞増殖促進剤や、かかる皮膚線維芽細胞増殖促進剤を含有するスキンケア飲食品やスキンケア化粧料を提供することにある。   Control of the proliferation of skin fibroblasts is considered important in considering skin care and skin aging. By controlling the proliferation and function of dermal fibroblasts, skin aging may be prevented, and it may be possible to maintain a youthful skin forever. The problem of the present invention is useful for combating wrinkles, which is the most common cosmetic problem, and is a safe dermal fibroblast proliferation promoter that can maintain skin elasticity and moisture by increasing water retention, An object of the present invention is to provide skin care foods and beverages and skin care cosmetics containing such a dermal fibroblast proliferation promoter.

月桃は、沖縄等の亜熱帯に群生するショウガ科の多年草で、世界の芳香植物164種の一つに数えられ、沖縄では古くから月桃の葉の抗菌性を生かして餅を包んだり、まんじゅうを葉に載せて蒸すという習慣があり、また、紙やお茶や畳などの用途に使用されていたが、近年、その抗菌効果を利用して、防腐剤を使用しない肌に優しい天然化粧品として利用されるようになっている。そして、この月桃には、メラニン色素の沈着抑制作用があり、化粧品を使用すると、紫外線によるシミ、そばかすを防ぐ効果があるといわれている。本発明者らは、月桃についてさらに検討を進め、乳酸菌等を用いた月桃の発酵処理物に、未発酵月桃には見い出すことができない、安定した皮膚線維芽細胞増殖促進作用があることを見い出し、本発明を完成するに至った。   Tsuki Peach is a ginger family perennial plant that grows in subtropics such as Okinawa and is counted as one of 164 species of aromatic plants in the world. In Okinawa, the antibacterial properties of moon peach leaves have long been used to wrap strawberries. Has been used for paper, tea, tatami mats, etc., but in recent years it has been used as a skin-friendly natural cosmetic that does not use preservatives due to its antibacterial effect. It has come to be. And this moon peach has an action to suppress the deposition of melanin pigment, and it is said that the use of cosmetics has the effect of preventing spots and freckles caused by ultraviolet rays. The present inventors have further studied about moon peach, and the processed product of moon peach using lactic acid bacteria, etc. has a stable skin fibroblast proliferation promoting action that cannot be found in unfermented moon peach. As a result, the present invention has been completed.

すなわち本発明は、(1)月桃を乳酸菌、乳酸菌と酵母、乳酸菌と枯草菌、又は乳酸菌と酵母と枯草菌により発酵させて得られる発酵処理物を有効成分とすることを特徴とする皮膚線維芽細胞増殖促進剤や、(2)発酵処理物が、月桃の葉の発酵処理物であることを特徴とする上記(1)記載の皮膚線維芽細胞増殖促進剤や、(3)ラクトバシルス・プランタリム、ストレプトコッカス・サーモフィルス、バシルス・ズブチルスの混合菌による発酵処理物であることを特徴とする上記(1)又は(2)記載の皮膚線維芽細胞増殖促進剤や、(4)発酵処理物が、抽出エキス又はその凍結乾燥物であることを特徴とする上記(1)〜(3)のいずれか記載の皮膚線維芽細胞増殖促進剤に関する。   That is, the present invention provides (1) a skin fiber characterized by containing as an active ingredient a fermented product obtained by fermenting moon peach with lactic acid bacteria, lactic acid bacteria and yeast, lactic acid bacteria and Bacillus subtilis, or lactic acid bacteria, yeast and Bacillus subtilis. A blast proliferation promoter, (2) the fermented product is a fermented product of moon peach leaves, (3) the dermal fibroblast proliferation promoter according to (1) above, A dermal fibroblast proliferation promoter according to (1) or (2) above, which is a fermented product by a mixed bacterium of plantalim, Streptococcus thermophilus, Bacillus subtilis, or (4) a fermented product Is an extract or a freeze-dried product thereof, and relates to the dermal fibroblast proliferation promoter according to any one of (1) to (3) above.

また本発明は、(5)上記(1)〜(4)のいずれか記載の皮膚線維芽細胞増殖促進剤を含有することを特徴とするスキンケア飲食品や、(6)さらに、シリマリン(Silymarin)、コラーゲンペプチド、及びヒアルロン酸から選ばれる1種以上の成分を含有することを特徴とする上記(5)記載のスキンケア飲食品に関する。   The present invention also provides (5) a skin care food or drink characterized by containing the dermal fibroblast proliferation promoter according to any one of (1) to (4) above, (6) and a silymarin (Silymarin) It contains 1 or more types of components chosen from collagen peptide and hyaluronic acid, It is related with the skin care food / beverage products of the said (5) description characterized by the above-mentioned.

さらに本発明は、(7)上記(1)〜(4)のいずれか記載の皮膚線維芽細胞増殖促進剤を含有することを特徴とするスキンケア化粧料や、(8)さらに、シリマリン(Silymarin)、コラーゲンペプチド、及びヒアルロン酸から選ばれる1種以上の成分を含有することを特徴とする上記(7)記載のスキンケア化粧料に関する。   Furthermore, the present invention provides (7) a skin care cosmetic comprising the dermal fibroblast proliferation promoter according to any one of (1) to (4) above, (8) and a Silymarin The skin care cosmetic according to (7) above, which contains one or more components selected from collagen peptides and hyaluronic acid.

本発明によると、線維芽細胞増殖促進効果により、美容上もっとも多い悩みとされるしわ対策に有用であり、保水性を高めて肌のはりや潤いを保つことが可能となる、安全なスキンケア飲食品やスキンケア化粧料を提供することができる。また、本発明によると、保水性を高めて肌のはりや潤いを保つことに加えて、メラニンの生成を抑制し、シミ、ソバカス、斑点又は妊娠期過色素沈着(hyperpigmenntation)を防止することもできる。   According to the present invention, the effect of promoting the proliferation of fibroblasts is useful for countermeasures against wrinkles, which are the most cosmetically annoying, and it is possible to increase the water retention and keep the skin firm and moisturized. Products and skin care cosmetics. Moreover, according to the present invention, in addition to maintaining water retention and keeping the skin firm and moist, it also suppresses the production of melanin, and prevents spots, buckwheat, spots, or hyperpigmenntation during pregnancy. it can.

本発明の皮膚線維芽細胞増殖促進剤としては、月桃を乳酸菌、乳酸菌と酵母、乳酸菌と枯草菌、又は乳酸菌と酵母と枯草菌により発酵させて得られる発酵処理物を有効成分とするものであれば特に制限されるものではなく、月桃の使用部位は、根、根茎等の地下部や、茎、葉、花、果実等の地上部であってもよく、また、これらの二種以上の混合物であってもよいが、葉の使用が特に好ましい。   The dermal fibroblast growth promoter of the present invention is an active ingredient that is obtained by fermenting moon peach with lactic acid bacteria, lactic acid bacteria and yeast, lactic acid bacteria and Bacillus subtilis, or lactic acid bacteria and yeast and Bacillus subtilis. There is no particular limitation as long as the peach peach is used in the underground part such as roots and rhizomes, and the above-ground part such as stems, leaves, flowers, and fruits. The use of leaves is particularly preferred.

上記乳酸菌としては、ストレプトコッカス属(Storeptococcus)、ラクトバシルス属(Lactobacillus)、ロイコノストック属(Leuconostoc)、ペディオコッカス属(Pediococcus)、ビフィドバクテリウム属(Bifidobacterium)又はテトラジェノコッカス属(Tetragenococcus)のいずれかに属する菌が好ましく、特にラクトバシルス属が好ましい。上記ストレプトコッカス属に属する菌としては、ストレプトコッカス・サーモフィルス(S. thermophilus)であることが好ましく、ストレプトコッカス・サーモフィルスIFO13957菌株を具体的に例示することができる。また、ラクトバシリルス属に属する菌としては、ラクトバシルス・プランタリム(L. plantrum)、ラクトバシルス・デルブリッキ(L. delbruckii)、ラクトバシルス・ペントサス(L. pentosus)又はラクトバシルス・カセイ(L. casei)のいずれかに属する菌であることが好ましく、これらの菌のうち、特にラクトバシルス・プランタリムが好ましい。かかるラクトバシルス・プランタリムとしてIFO14712菌株やIFO14713菌株を、ラクトバシルス・デルブリッキとしてIFO13953菌株を、ラクトバシルス・ペントサスとしてIFO12011菌株を、ラクトバシルス・カセイとしてIFO15883菌株を、それぞれ具体的に例示することができる。また、テトラジェノコッカス属に属する菌としては、テトラジェノ・ハロフィルス(T. halophilus)であることが好ましく、テトラジェノ・ハロフィルスIFO12172菌株を具体的に例示することができる。これら乳酸菌は、月桃の葉の乾物1gあたり、通常10〜10個、特に10〜10個用いることが好ましい。 Examples of the lactic acid bacteria include Streptococcus, Lactobacillus, Leuconostoc, Pediococcus, Bifidobacterium, and Tetragenococcus. Bacteria belonging to any of these are preferred, and Lactobacillus is particularly preferred. The bacterium belonging to the genus Streptococcus is preferably Streptococcus thermophilus (S. thermophilus), and specific examples include Streptococcus thermophilus IFO13957 strain. In addition, as a bacterium belonging to the genus Lactobacillus, any of Lactobacillus plantarim (L. plantrum), Lactobacillus delbruckii (L. delbruckii), Lactobacillus pentosus (L. pentosus) or Lactobacillus casei (L. casei) Among these bacteria, Lactobacillus plantarim is particularly preferable. Specific examples of such Lactobacillus plantarim include IFO14712 and IFO14713 strains, Lactobacillus delbriqui as IFO13953 strain, Lactobacillus pentosus as IFO12011 strain, and Lactobacillus casei as IFO15883 strain. Moreover, as a microbe which belongs to Tetragenococcus genus, it is preferable that it is Tetrageno halophyllus (T. halophilus), and tetrageno halophyllus IFO12172 strain can be illustrated concretely. These lactic acid bacteria, dry basis 1g leaf month peach, usually 10 3 to 10 7, it is preferable to use particularly 10 6 to 10 7.

また、上記酵母としては、カンジダ属(Candida)又はサッカロマイセス属(Saccharomyces)に属する菌が好ましい。かかるカンジダ属に属する菌として、カンジダ・ビルサチルス(Candida versatilis)であることが好ましく、カンジダ・ビルサチルスとしてIFO10038菌株を具体的に例示することができる。サッカロマイセス属に属する菌として、サッカロマイセス・セレビシアエ(S. cerevisiae)であることが好ましく、サッカロマイセス・セレビシアエとしてIFO0555菌株を具体的に例示することができる。これら酵母菌は、主として香りの改善のために添加され、この場合、モモタマナの葉の乾物1gあたり、通常10〜10個、特に10〜10個用いることが好ましい。 Moreover, as said yeast, the microbe which belongs to Candida (Candida) or Saccharomyces (Saccharomyces) is preferable. As such a bacterium belonging to the genus Candida, Candida versatilis is preferable, and IFO10038 strain can be specifically exemplified as Candida versatilis. The bacterium belonging to the genus Saccharomyces is preferably S. cerevisiae, and IFO0555 strain can be specifically exemplified as Saccharomyces cerevisiae. These yeast are added primarily to improve the aroma, in this case, dry basis 1g leaf Terminalia catappa, usually 10 3 to 10 7, it is preferable to use particularly 10 6 to 10 7.

また、上記枯草菌としては、バシルス・ズブチルス(B. subtilis)IFO3013菌株を具体的に例示することができる。これら枯草菌は、月桃の葉の乾物1gあたり、通常10〜10個、特に10〜10個用いることが好ましい。 Further, as the Bacillus subtilis, a B. subtilis IFO3013 strain can be specifically exemplified. These B. subtilis, dry basis 1g leaf month peach, usually 10 3 to 10 7, it is preferable to use particularly 10 6 to 10 7.

月桃の発酵処理において、好ましく用いられる微生物群としては、乳酸菌と枯草菌を含む微生物群が好ましく、これら微生物群の中でも、ラクトバシルス・プランタリム、ストレプトコッカス・サーモフィルス、バシルス・ズブチルスの混合菌であることが好ましく、これらは月桃の葉の乾物に対し、菌数として同数を使用することが好ましい。このような菌数の組合せにより、発酵時間の短縮を図り、ひいては雑菌の繁殖を抑制することができる。   As a group of microorganisms preferably used in the fermentation process of moon peach, a group of microorganisms containing lactic acid bacteria and Bacillus subtilis is preferable, and among these microorganism groups, a mixed bacteria of Lactobacillus plantarim, Streptococcus thermophilus, Bacillus subtilis It is preferable to use the same number as the number of bacteria for dry matter of moon peach leaves. By such a combination of the number of bacteria, it is possible to shorten the fermentation time and to suppress the propagation of various bacteria.

上記月桃の発酵処理においては、月桃の葉の乾燥体を、3mm以下、好ましくは0.5〜1.0mmの粒径まで粉砕する。3mm以下の粒径とすることにより、発酵菌との接触面積を十分に確保することができ、発酵を効果的に進行させることができ、0.5〜1.0mmの範囲の粒径であれば、かかる効果がより顕著に得られる。このような植物の粉砕物に、発酵の進行を促進するため、乾物1重量部に対し、1〜10重量部、特に4〜6重量部程度の水分を添加することが好ましい。かかる乾燥粉砕物に、上述の菌又は菌群を添加する。菌群は各々菌を培養後、培地へ添加する前に予め混合し、乾燥体である場合の植物の重量に対して、1〜10重量%(培養物として)添加することが好ましい。発酵は、温度20〜50℃、中でも40℃前後で行われることが好ましく、発酵時間は、pHや、菌数等の条件による発酵の進行状況や、嗜好により適宜選択することができ、例えば、pH4〜5、菌数10以上であれば、約72時間とするのが好ましい。発酵処理時、必要に応じてエアレーションや脱酸素処理を行うことができるが、脱酸素処理後に静置培養において発酵させることができる。発酵形式は、液体培養でなく固体培養が好ましい。 In the moon peach fermentation treatment, the dried body of moon peach leaves is pulverized to a particle size of 3 mm or less, preferably 0.5 to 1.0 mm. By setting the particle size to 3 mm or less, a sufficient contact area with the fermenting bacteria can be secured, fermentation can proceed effectively, and the particle size in the range of 0.5 to 1.0 mm. This effect can be obtained more remarkably. In order to promote the progress of fermentation, it is preferable to add 1 to 10 parts by weight, particularly about 4 to 6 parts by weight, of water to 1 part by weight of dry matter. The above-mentioned bacteria or fungal group is added to the dried pulverized product. It is preferable to mix 1 to 10% by weight (as a culture) of the fungal group after the culture of each fungus, before mixing to the medium and before adding to the medium. Fermentation is preferably performed at a temperature of 20 to 50 ° C., particularly around 40 ° C., and the fermentation time can be appropriately selected depending on the progress of fermentation under conditions such as pH and the number of bacteria, and preference. pH 4-5, if the bacteria number 10 6 or more, preferably about 72 hours. At the time of fermentation treatment, aeration or deoxygenation treatment can be performed as necessary, but fermentation can be performed in static culture after the deoxygenation treatment. The fermentation format is preferably solid culture rather than liquid culture.

かかる発酵処理において、発酵菌の資化剤として炭水化物や蛋白質を添加することができる。資化剤としての炭水化物は市販のブドウ糖、蔗糖、廃糖蜜等の糖が好ましく、これらの添加量としては培地当たり1〜10重量%が好ましく、特に3重量%前後が適当である。資化剤としての蛋白質は米糠、ふすま等が好ましく、これらの添加量としては培地当たり1〜5重量%が好ましい。これらの資化剤は1種を単独で、又は2種以上を混合して用いてもよい。   In such a fermentation treatment, carbohydrates and proteins can be added as an agent for fermenting bacteria. The carbohydrate as the assimilating agent is preferably a commercially available sugar such as glucose, sucrose, molasses, etc., and the amount of these added is preferably 1 to 10% by weight per medium, particularly around 3% by weight. The protein as an assimilating agent is preferably rice bran, bran or the like, and the addition amount thereof is preferably 1 to 5% by weight per medium. These assimilating agents may be used alone or in combination of two or more.

本発明の皮膚線維芽細胞増殖促進剤の有効成分としての発酵処理物としては、発酵した物や、発酵した物に乾燥処理、滅菌処理、抽出処理、酵素処理等の1又は2以上の処理を施した処理物を挙げることができる。例えば、発酵終了後、乾燥処理により水分値が10重量%以下となるように乾燥することもできる。乾燥方法としては、加熱乾燥や凍結乾燥によることができ、加熱乾燥の場合は、品温が100℃以下で行われることが、生理活性成分の失活を防止することができるため好ましい。また、乾燥後、必要に応じて加熱等公知の方法により滅菌処理を行うこともできる。本発明の皮膚線維芽細胞増殖促進剤の有効成分としての発酵処理物としては、月桃を発酵後乾燥して抽出した抽出エキスを特に好適に例示することができる。かかる抽出処理に使用する溶媒としては、例えば、水(熱水)、メチルアルコール、エチルアルコール等の低級1価アルコールや、グリセリン、プロピレングリコール、1,3−ブチレングリコール等の液状多価アルコール、ヘキサン等の非極性溶媒の一種又は二種以上を挙げることができる。好ましい抽出方法としては、例えば、70〜90℃の水での10〜60分の熱水抽出、好ましくは80℃の水での20分間の熱水抽出した後濾過する方法や、濃度80容量%のエチルアルコールを用い、室温で24時間抽出した後濾過する方法等を挙げることができる。更に、熱水抽出物を凍結乾燥した凍結乾燥処理物や、アルコール等の溶媒抽出処理物の溶媒を除去した後凍結乾燥した凍結乾燥処理物を有利に使用することができ、また、必要に応じてこれらの抽出物を溶媒と混合し混合液としたものも使用することができる。   As the fermented product as an active ingredient of the dermal fibroblast growth promoter of the present invention, the fermented product or the fermented product is subjected to one or more treatments such as drying treatment, sterilization treatment, extraction treatment, enzyme treatment and the like. Examples of the treated product are listed. For example, after completion of fermentation, it can be dried by a drying process so that the moisture value becomes 10% by weight or less. The drying method may be heat drying or freeze drying. In the case of heat drying, it is preferable that the product temperature is 100 ° C. or lower because the deactivation of the physiologically active component can be prevented. Further, after drying, if necessary, sterilization can be performed by a known method such as heating. As the fermented processed product as an active ingredient of the dermal fibroblast growth promoter of the present invention, an extract obtained by extracting and extracting moon peach after drying can be particularly preferably exemplified. Examples of the solvent used for the extraction treatment include lower monohydric alcohols such as water (hot water), methyl alcohol, and ethyl alcohol, liquid polyhydric alcohols such as glycerin, propylene glycol, and 1,3-butylene glycol, and hexane. One type or two or more types of nonpolar solvents such as As a preferable extraction method, for example, a hot water extraction with water at 70 to 90 ° C. for 10 to 60 minutes, preferably a hot water extraction with water at 80 ° C. for 20 minutes and a filtration, or a concentration of 80% by volume And a method of performing extraction for 24 hours at room temperature and then filtering. Furthermore, a freeze-dried product obtained by freeze-drying a hot water extract or a freeze-dried product obtained by removing a solvent from a solvent extraction product such as alcohol and then freeze-drying can be advantageously used. It is also possible to use a mixture obtained by mixing these extracts with a solvent.

上記抽出液、抽出液から溶媒を留去して得られる抽出物、あるいはこれら抽出物のスプレードライ品や凍結乾燥品は、そのままでも皮膚線維芽細胞増殖促進剤として使用可能であるが、これらの作用に影響しない範囲で、脱臭、脱色等のための精製処理を施してもよい。さらに、液液分配抽出、各種クロマトグラフィー、イオン交換、膜分離等の分離精製処理を施して、活性の強い皮膚線維芽細胞増殖促進剤として使用することができる。   The above extract, an extract obtained by distilling off the solvent from the extract, or a spray-dried product or freeze-dried product of these extracts can be used as a dermal fibroblast proliferation promoter as they are. You may perform the refinement | purification process for deodorizing, decoloring, etc. in the range which does not affect an effect | action. Furthermore, it can be used as an active skin fibroblast proliferation promoter by performing separation and purification treatment such as liquid-liquid partition extraction, various chromatography, ion exchange, membrane separation and the like.

上記のようにして得られた月桃の発酵処理物を有効成分とする皮膚線維芽細胞増殖促進剤は、それ自体でまたは薬学的に許容される結合剤、安定化剤、賦形剤、希釈剤、pH緩衝剤、崩壊剤、可溶化剤、溶解補助剤などと混合して液体、粉末、顆粒、錠剤、カプセル剤等として用いることができる他、食品・食品素材に添加・配合して本発明のスキンケア飲食品としたり、化粧料・化粧料素材に添加・配合して本発明のスキンケア化粧料とすることができる。本発明のスキンケア飲食品やスキンケア化粧料には、公知のスキンケア成分と併用することもできる。かかるスキンケア成分としては、シリマリン(Silymarin)、コラーゲンペプチド、ヒアルロン酸、コエンザイムQ10、グルコサミン、ビタミンC等を挙げることができ、これらは1種又は2種以上併用することができる。 The dermal fibroblast growth promoter comprising as an active ingredient the fermentation product of moon peach obtained as described above is itself or a pharmaceutically acceptable binder, stabilizer, excipient, dilution. Can be used as liquids, powders, granules, tablets, capsules, etc. by mixing with agents, pH buffers, disintegrants, solubilizers, solubilizers, etc. It can be used as the skin care food / beverage product of the invention, or added to and blended with a cosmetic / cosmetic material to obtain the skin care cosmetic of the present invention. The skin care food and drink and skin care cosmetics of the present invention can be used in combination with known skin care ingredients. Examples of such skin care ingredients include silymarin, collagen peptide, hyaluronic acid, coenzyme Q 10 , glucosamine, vitamin C and the like, and these can be used alone or in combination of two or more.

上記シリマリンは、キク科マリアアザミから抽出されるフラボノリグナンの総称であり、確認されている主要成分はシリビン、シリジアニン、シリクリスチン、イソシリビンなどがあり、前記キク科マリアアザミの植物の種実からエタノール抽出し、スプレードライにより乾燥粉末として得られるエキス原料として市販されている。本発明に使用するシリマリンは市販されているシリマリンをそのまま用いることもでき、また、上記コラーゲンペプチド、ヒアルロン酸、コエンザイムQ10、グルコサミン、ビタミンC等は、いずれも市販されているものを使用することができる。例えば、発酵月桃抽出エキス(凍結乾燥品)、シリマリン、コラーゲンペプチド、ヒアルロン酸からなるしわ予防用組成物の場合、発酵月桃抽出エキス(凍結乾燥品)15〜25重量%、シリマリン0.1〜1.0重量%、コラーゲンペプチド70〜80重量%、ヒアルロン酸0.1〜0.2重量%の配合品を好適に例示することができる。 The above silymarin is a generic name for flavonolignans extracted from Asteraceae Maria thistle, and the main components that have been identified include silybin, silydianin, silycristin, isosiribin, etc., extracted from the seeds of the Asteraceae maria thistle And it is marketed as an extract raw material obtained as a dry powder by spray drying. As the silymarin used in the present invention, commercially available silymarin can be used as it is, and the collagen peptide, hyaluronic acid, coenzyme Q 10 , glucosamine, vitamin C and the like are all commercially available. Can do. For example, in the case of a wrinkle-preventing composition comprising fermented moon peach extract (lyophilized product), silymarin, collagen peptide, hyaluronic acid, fermented moon peach extract (lyophilized product) 15 to 25% by weight, silymarin 0.1 Preferred examples include -1.0 wt%, collagen peptide 70-80 wt%, and hyaluronic acid 0.1-0.2 wt%.

上記本発明のスキンケア飲食品の種類・形態としては、例えば、ヨーグルト、ドリンクヨーグルト、ジュース、牛乳、豆乳、酒類、コーヒー、紅茶、煎茶、ウーロン茶、スポーツ飲料等の各種飲料や、プリン、クッキー、パン、ケーキ、煎餅などの焼き菓子、羊羹などの和菓子、冷菓、ゼリー、チューインガム等のパン・菓子類や、うどん、そば等の麺類や、かまぼこ、ハム、魚肉ソーセージ等の魚肉練り製品や、みそ、しょう油、ドレッシング、マヨネーズ、甘味料等の調味類や、チーズ、バター等の乳製品や、豆腐、こんにゃく、その他佃煮、餃子、コロッケ、サラダ等の各種総菜や、蜂蜜、ローヤルゼリー、栄養補助食品 、老人・病人・乳幼児食、非常食、ダイエット食などを挙げることができ、通常、パッケージングや説明書等に、美容上もっとも多い悩みとされるしわ対策に有用であり、保水性を高めて肌のはりや潤いを保つことができる旨が表示されて販売される。   Examples of the types and forms of the skin care food and drink of the present invention include, for example, yogurt, drink yogurt, juice, milk, soy milk, liquor, coffee, tea, sencha, oolong tea, sports drinks, pudding, cookies, bread Baked confectionery such as cake, rice cracker, Japanese confectionery such as sheep crab, bread and confectionery such as frozen confectionery, jelly and chewing gum, noodles such as udon and soba, fish paste products such as kamaboko, ham and fish sausage, miso and soy sauce , Seasonings such as dressing, mayonnaise, sweeteners, dairy products such as cheese and butter, various prepared dishes such as tofu, konjac, other boiled fish, dumplings, croquettes, salads, honey, royal jelly, dietary supplements, Sick and infant food, emergency food, diet food, etc. can be mentioned, usually in packaging and instructions etc. It is useful for combating wrinkles, which is considered the most cosmetic problem, and is sold with the indication that it can maintain the elasticity and moisture of the skin by increasing water retention.

また、上記本発明のスキンケア化粧料の種類・形態としては、例えば、ローション、乳液、クリーム、ファンデーション、下地料、白粉、頬紅、日焼け止め料などを挙げることができ、通常、パッケージングや説明書等に、美容上もっとも多い悩みとされるしわ対策に有用であり、保水性を高めて肌のはりや潤いを保つことができる旨が表示されて販売される。   Examples of the type and form of the skin care cosmetics of the present invention include, for example, lotions, emulsions, creams, foundations, base materials, white powder, blushers, sunscreens, etc. For example, it is useful for combating wrinkles, which are considered the most troublesome cosmetics, and it is displayed and sold to show that it can maintain water elasticity and moisturize the skin.

以下、実施例により本発明をより具体的に説明するが、本発明の技術的範囲はこれらの例示に限定されるものではない。   EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, the technical scope of this invention is not limited to these illustrations.

(発酵月桃の熱水抽出物の調製)
乾燥した月桃の葉30gを0.1〜3mmの粒径に粉砕し容器に入れた。粉砕月桃を入れた容器に水30g、糖蜜0.9gを添加した。これとは別に、ラクトバシルス・プランタリム、ストレプトコッカス・サーモフィルス、バシルス・ズブチルスの各菌をそれぞれ培養後、菌数1:1:1の割合で混合し、月桃の重量に対し、10重量%を添加し、容器を密閉し、静置培養により発酵を行った。発酵温度は40℃、発酵時間は72時間とした。その後、乾燥機により水分値が10重量%以下になるまで60℃で乾燥した後、滅菌処理(130℃蒸気、5〜15秒)を行い、発酵月桃30gを得た(以下「発酵月桃茶」という場合がある)。その後、発酵月桃茶1gに対して10mLの割合になるように水を加え、80℃で20分間熱水抽出し、上澄みをプールし、沈殿1gに対して10mLの割合になるように再度、水を加え、80℃で20分間熱水抽出し、前述の上澄みと合わせて熱水抽出エキスを得た。また、この熱水抽出エキスを凍結乾燥して得られる発酵月桃凍結乾燥物(熱水抽出物)(収率9.12%)を調製した。
(Preparation of hot water extract of fermented moon peach)
30 g of dried moon peach leaves were pulverized to a particle size of 0.1 to 3 mm and placed in a container. 30 g of water and 0.9 g of molasses were added to a container containing crushed moon peach. Separately, after each culture of Lactobacillus plantarim, Streptococcus thermophilus, and Bacillus subtilis was mixed at a ratio of 1: 1: 1, 10% by weight with respect to the weight of moon peach The mixture was added, the container was sealed, and fermentation was performed by static culture. The fermentation temperature was 40 ° C. and the fermentation time was 72 hours. Then, after drying at 60 degreeC until the moisture value became 10 weight% or less with a dryer, the sterilization process (130 degreeC steam, 5-15 seconds) was performed, and 30 g of fermented moon peach was obtained (henceforth "fermented moon peach"). Sometimes called "tea"). Then, add water so that it becomes a ratio of 10 mL with respect to 1 g of fermented moon peach tea, extract with hot water at 80 ° C. for 20 minutes, pool the supernatant, and again so that the ratio becomes 10 mL with respect to 1 g of precipitate. Water was added, hot water extraction was performed at 80 ° C. for 20 minutes, and a hot water extract was obtained together with the supernatant. Moreover, fermented moon peach freeze-dried product (hot water extract) (yield 9.12%) obtained by freeze-drying this hot-water extract was prepared.

(発酵月桃のアルコール抽出物の調製)
実施例1と同様にして調製した発酵月桃茶1gに対して10mLの割合になるように80%エタノールを加え、室温で24時間抽出し、この抽出液を濃縮、乾固し、濃度20mg/mlになるようにDMSOを加え再溶解して、抽出物を調製した。
(Preparation of fermented moon peach alcohol extract)
80% ethanol was added so that it might become a ratio of 10 mL with respect to 1 g of fermented moon peach tea prepared similarly to Example 1, and it extracted at room temperature for 24 hours, this extract liquid was concentrated and dried, and concentration 20 mg / The extract was prepared by adding DMSO to make up to ml and re-dissolving.

(皮膚線維芽細胞増殖試験:熱水抽出液の使用)
皮膚線維芽細胞(ヒト新生児由来、大日本製薬株式会社より購入、1×10)を、10%FBSを含むα−MEM培地を用いて、25cmフラスコ中で4日間培養した。その後トリプシン処理して細胞を回収し、7×10cell/mLで24穴プレートに移し5%FBSを含むα−MEM培地で12時間培養した。次に、サンプルである発酵月桃の熱水抽出液を原液又は5倍希釈したもの5μLを皮膚線維芽細胞に添加し、37℃、5%COにて3日間培養した。コントロールとして抽出物無添加を、また、月桃の葉の無醗酵乾燥物も、同様に上記の条件で培養したものを用いた。比色法の一つであるMTT法にて細胞生存率を測定し、細胞増殖率を細胞増殖率(%)=[(A−C)−(B−D)/(B−D)]×100により求めた。式中、A:MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide)添加、熱水抽出液添加、B:MTT添加、熱水抽出液無添加、C:MTT無添加、熱水抽出液添加、D:MTT無添加、熱水抽出液無添加、をそれぞれ示す。結果を図1に示す。図1より、本発明の月桃発酵処理物の熱水抽出液を添加したものは、細胞増殖率は、コントロールに比べて約12〜17%高く、月桃を醗酵しないものと比べると約9〜11%高いことがわかった。なお、5倍希釈の方が原液より細胞増殖率がよいがその理由は不明である。
(Skin fibroblast proliferation test: Use of hot water extract)
Skin fibroblasts (derived from a human newborn, purchased from Dainippon Pharmaceutical Co., Ltd., 1 × 10 6 ) were cultured for 4 days in a 25 cm 2 flask using an α-MEM medium containing 10% FBS. Thereafter, the cells were collected by trypsin treatment, transferred to a 24-well plate at 7 × 10 3 cells / mL, and cultured for 12 hours in an α-MEM medium containing 5% FBS. Next, 5 μL of a sample of the hot water extract of fermented moon peach as a sample or a 5-fold dilution was added to the dermal fibroblasts and cultured at 37 ° C. and 5% CO 2 for 3 days. As a control, no extract was added, and a non-fermented dried product of moon peach leaves was also cultured under the same conditions. The cell viability is measured by the MTT method, which is one of the colorimetric methods, and the cell growth rate is expressed as cell growth rate (%) = [(AC) − (BD) / (BD)] × 100. In the formula, A: MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyl tetrazolium bromide) added, hot water extract added, B: MTT added, no hot water extract added, C : No MTT added, hot water extract added, D: no MTT added, no hot water extract added. The results are shown in FIG. As shown in FIG. 1, the cell growth rate of the product obtained by adding the hot water extract of the processed product of the moon peach fermentation of the present invention is about 12 to 17% higher than that of the control, and about 9 compared with that not fermenting the moon peach. It was found to be ˜11% higher. Although the 5-fold dilution has better cell growth rate than the stock solution, the reason is unknown.

(皮膚線維芽細胞増殖試験:80%エタノール抽出物の使用)
実施例2で調製した80%エタノール抽出物をDMSOに溶解し、最終濃度10μg/mL、又は4μg/mLとなるように用いて、実施例3と同様に細胞増殖率を求めた。結果を図2に示す。図2より、エタノール抽出物を添加した場合の細胞増殖率は、コントロールに比べて、10μg/mLでは約5%、4μg/mLでは約18%高いことがわかった。また、月桃を醗酵しないものと比べると、10μg/mLでは約61%、4μg/mLでは約18%高いことがわかった。なお、この実験でも4μg/mLの方が、10μg/mLより細胞増殖率がよいがその理由は不明である。
(Skin fibroblast proliferation test: use of 80% ethanol extract)
The 80% ethanol extract prepared in Example 2 was dissolved in DMSO and used at a final concentration of 10 μg / mL or 4 μg / mL, and the cell growth rate was determined in the same manner as in Example 3. The results are shown in FIG. From FIG. 2, it was found that the cell proliferation rate when the ethanol extract was added was about 5% at 10 μg / mL and about 18% at 4 μg / mL compared to the control. It was also found that 10 μg / mL was about 61% higher and 4 μg / mL was about 18% higher than the one that did not ferment moon peach. In this experiment, the cell growth rate is better at 4 μg / mL than at 10 μg / mL, but the reason is unknown.

(発酵月桃茶のモニターテスト)
20代〜50代の女性20名を対象として、発酵月桃茶のアンケート調査を行った。実施例1で得られた発酵月桃茶2gを1リットルの水に入れ火にかけ、沸騰後5分間煮出した。この煮出液を1日500mL以上毎日摂取してもらい、8週間後に「肌のはり」、「肌の潤い」及び「肌のつや」についてアンケート調査を行った。アンケートは5段階評価(改善、やや改善、不変、やや悪化、悪化)にて実施した。肌のはりについてのアンケート結果を表1に、肌の潤いについてのアンケート結果を表2に、肌のつやについてのアンケート結果を表3に、それぞれ示す。
(Monitor test of fermented moon peach tea)
A questionnaire survey of fermented moon peach tea was conducted for 20 women in their 20s to 50s. 2 g of fermented moon peach tea obtained in Example 1 was placed in 1 liter of water and ignited, and boiled for 5 minutes after boiling. This boiled liquid was ingested daily by 500 mL or more, and after 8 weeks, a questionnaire survey was conducted on “skin tension”, “skin moisture” and “skin gloss”. The questionnaire was conducted with a five-level evaluation (improvement, slightly improved, unchanged, slightly worsened, worsened). Table 1 shows the results of the questionnaire regarding skin tension, Table 2 shows the results of questionnaire about moisture, and Table 3 shows the results of questionnaire regarding skin gloss.

肌のはりについてのアンケート結果(表1)によると、21名中12名(57%)の方が改善又はやや改善したと回答しており、肌の潤いについてのアンケート結果(表2)によると、21名中10名(47%)の方が改善又はやや改善したと回答しており、肌のつやについてのアンケート結果(表3)によると21名中9名が改善又はやや改善したと回答していることからも明らかなように、本発明の皮膚線維芽細胞増殖促進剤には、「肌のはり」、「肌の潤い」及び「肌のつや」について効果を奏することがわかった。   According to the questionnaire results (Table 1) about skin tension, 12 out of 21 (57%) answered that they improved or slightly improved, and according to the questionnaire results (Table 2) about skin moisture , 10 out of 21 (47%) replied that it was improved or slightly improved, and according to the questionnaire results (Table 3) on skin gloss, 9 out of 21 replied that it improved or slightly improved As is clear from the above, it has been found that the skin fibroblast proliferation promoter of the present invention has an effect on “skin elasticity”, “skin moisture” and “skin gloss”.

(発酵月桃エキス粒のモニターテスト)
20代〜40代の女性6名を対象として、55日間モニターテストを実施してもらった。モニターを実施する前の肌状態を皮膚粘弾性測定装置CUTOMETERMPA580で肌(頬)のエリスマ(赤み)および弾力の測定を行った。発酵月桃エキス粒(実施例1における発酵月桃熱水抽出物の凍結乾燥物の粒剤;200mg×4粒)を就寝前(20時〜22時)にモニター期間中毎日服用してもらい、モニター開始から55日目に、同様に肌のエリスマおよび弾力の測定を行った。測定方法として、エリスマについてはプローブを各部位に直接当てプログラム上でデータ処理し、弾力に関しては、測定部位にプローブを当て吸引後、圧解除し、時間に対する変位を測定し、その波形から弾力を計算によって算出し評価した。測定環境は、温度25±1℃、湿度53〜63%であった。その結果を、エリスマ赤み(頬)については、個人別データを図3に、平均をとり統計処理(t検定)を行った結果を図4に示す。図3および図4より、どの被験者も減少傾向にあり、統計処理の結果から摂取前と比較して摂取後は有意に減少した。
(Monitor test of fermented moon peach extract grains)
A 55-day monitoring test was conducted on 6 women in their 20s and 40s. The skin state before monitoring was measured for skin (cheek) erythema (redness) and elasticity with a skin viscoelasticity measuring device CUTERTERMER 580. Fermented moon peach extract granules (granule of freeze-dried fermented moon peach extract in Example 1; 200 mg × 4 grains) were taken every day during the monitoring period before going to bed (20: 00-22: 00), On the 55th day after the start of monitoring, the skin erythema and elasticity were similarly measured. As for the measurement method, for the erythema, the probe is directly applied to each part and data processing is performed on the program.For the elasticity, the probe is applied to the measurement part and suctioned, the pressure is released, the displacement with respect to time is measured, and the elasticity is calculated from the waveform. Calculated and evaluated by calculation. The measurement environment was a temperature of 25 ± 1 ° C. and a humidity of 53 to 63%. The results are shown in FIG. 3 for individual data for erythema redness (cheek), and the result of statistical processing (t-test) taking the average is shown in FIG. 3 and 4, all subjects tended to decrease, and the results of statistical processing showed a significant decrease after ingestion compared to before intake.

弾力の測定試験の結果を、波形モデルについては図5に、弾力個人別データは図6に、平均値は図7に示す。図5の波形モデルで示すように吸引時の引っ張りの最大値から圧解除時の最小値を差し引いた値を吸引時の最大値で割った値を弾力と評価する。一人の被験者を除き、どの被験者も弾力が増加傾向にあった。グラフの縦軸は上記波形モデルで示したR2の値であるが、1に近づけば近づくほど完全弾性体に近く、弾力があると評価される。図6、図7より、平均をとり統計処理を行った結果、有意差はなかったものの摂取前と比較して摂取後は弾力に増加傾向が見られた。このように発酵月桃エキス粒の肌物性へ与える効果としては、肌の弾力の増加、エリスマ(赤み)の改善があることがわかった。
[参考例1]
The results of the elasticity measurement test are shown in FIG. 5 for the waveform model, FIG. 6 for the individual data for elasticity, and FIG. 7 for the average value. As shown in the waveform model of FIG. 5, a value obtained by subtracting the minimum value at the time of releasing pressure from the maximum value at the time of suction and dividing by the maximum value at the time of suction is evaluated as elasticity. Except for one subject, all subjects tended to increase their elasticity. The vertical axis of the graph is the value of R2 shown in the waveform model, but the closer it is to 1, the closer it is to a perfect elastic body, and it is evaluated that there is elasticity. As shown in FIGS. 6 and 7, statistical processing was performed by taking an average. As a result, although there was no significant difference, there was an increase in elasticity after ingestion compared with before ingestion. As described above, it was found that the effects of fermented moon peach extract grains on the skin physical properties include an increase in skin elasticity and an improvement in erythema (redness).
[Reference Example 1]

(メラニン生成量の測定)
メラニン量、DNA量を測定し、DNA当たりのメラニン生成量を測定した。また、供試サンプルとして、実施例1における発酵月桃熱水抽出物の凍結乾燥物を、ビタミンCとしてL(+)アスコルビン酸ナトリウム(Wako社製)をPBS(−)溶液に溶解したものを加え、0.22μmフィルターで濾過滅菌した液を用いた。サンプル溶液は細胞増殖に影響を与えないよう、培地に対して1%以下になるように調製した。
(1)測定試料の調製:細胞として、B16メラノーマ細胞(理研セルバンクより購入、B16melanoma 4A5:Car No RCB0557)を10%FBS−MEM(pH7.4)培地で、所定濃度のサンプル溶液を添加して37℃、5%COにて3日間培養した。培地を除去し、PBS(−)溶液で細胞表面を2回洗浄し、その後50mM Tris−HCl buffer(pH7.5)を1mL加え、細胞をセルスクレイバー(Nunc社製)で集め、ソニケーター(Yamato powersonic社製 Model150)で破砕した。これを細胞破砕液とした。
(2)メラニン量の測定:(1)の細胞破砕液0.5mLに2N NaOHを0.5mL加え、80℃で加温し、メラニンを溶解した。冷却後、400nmの吸光度を測定した。メラニン標準液を用いて検量線を作成し、メラニン量を算出した。
(3)DNA量の測定:(1)の細胞破砕液80μにDAPI(4’,6−Diamidino-2-phenylindole(DAPI)[SIGMA]1mg/20mL Tris-HCI buffer(pH7.5)をストック溶液として−20℃で遮光保存。使用時にTris-HCI buffer(pH7.5)で500倍に希釈した。)を4mL加えて混合し、暗所に30分間置いた。励起波長(Ex)350nm、蛍光強度を測定した(Shimadzu spectofluorophotometer RF-540)。DNA標準液を用いて検量線を作成し、DNA量を算出した。
(Measurement of melanin production)
The amount of melanin and the amount of DNA were measured, and the amount of melanin produced per DNA was measured. Further, as a test sample, a freeze-dried product of fermented moon peach hot water extract in Example 1 and a solution of L (+) sodium ascorbate (manufactured by Wako) dissolved in PBS (−) solution as vitamin C. In addition, a solution sterilized by filtration with a 0.22 μm filter was used. The sample solution was prepared to be 1% or less with respect to the medium so as not to affect cell growth.
(1) Preparation of measurement sample: B16 melanoma cells (purchased from Riken Cell Bank, B16melanoma 4A5: Car No RCB0557) are added as a cell in 10% FBS-MEM (pH 7.4) medium and a sample solution of a predetermined concentration is added. The cells were cultured at 37 ° C. and 5% CO 2 for 3 days. The medium was removed, the cell surface was washed twice with PBS (−) solution, 1 mL of 50 mM Tris-HCl buffer (pH 7.5) was then added, and the cells were collected with a cell scraper (manufactured by Nunc), and the sonicator (Yamato powersonic It was crushed with Model 150). This was used as a cell lysate.
(2) Measurement of melanin amount: 0.5 mL of 2N NaOH was added to 0.5 mL of the cell disruption solution of (1) and heated at 80 ° C. to dissolve melanin. After cooling, the absorbance at 400 nm was measured. A calibration curve was prepared using a melanin standard solution, and the amount of melanin was calculated.
(3) Measurement of DNA amount: DAPI (4 ′, 6-Diamidino-2-phenylindole (DAPI) [SIGMA] 1 mg / 20 mL Tris-HCI buffer (pH 7.5)) in 80 μm of the cell disruption solution of (1) 4 mL of Tris-HCI buffer (pH 7.5) was diluted at the time of use and mixed, and the mixture was placed in the dark for 30 minutes. The excitation wavelength (Ex) was 350 nm, and the fluorescence intensity was measured (Shimadzu spectofluorophotometer RF-540). A calibration curve was prepared using a DNA standard solution, and the amount of DNA was calculated.

無醗酵の月桃と醗酵させた月桃(月桃茶)の濃度を、0(コントロール)、25、50、100,150(μg/mL medium)としたものと、ビタミンC(比較例)を50(μg/mL medium)用いた場合のB16メラノーマ細胞のメラニン生成量に及ぼす影響(効果)を、前記(2)、(3)のメラニンの測定、DNAの測定量の方法を採用して行った。結果を図8に示す。図8より、コントロールに比べて、無醗酵の月桃と醗酵させた月桃(月桃茶)何れもメラニン生成に対する抑制の程度は高く、25〜100(μg/mL medium)の範囲では濃度が高くなるほど抑制力が比例して高いが、150(μg/mL medium)では、100(μg/mL medium)よりは、いくらか劣っている。いずれの濃度の場合もビタミンCよりメラニン生成量を抑えていることがわかった。しかし、無醗酵の月桃と醗酵させた月桃(月桃茶)の間にはほとんど差が見出せなかった。
[参考例2]
Concentration of non-fermented moon peach and fermented moon peach (moon peach tea) was 0 (control), 25, 50, 100, 150 (μg / mL medium), and vitamin C (comparative example) The effect (effect) exerted on the amount of melanin produced by B16 melanoma cells when 50 (μg / mL medium) is used is determined by adopting the methods for measuring melanin and measuring DNA in (2) and (3) above. It was. The results are shown in FIG. From FIG. 8, compared with the control, both the non-fermented moon peach and the fermented moon peach (moon peach tea) have a high degree of inhibition of melanin production, and the concentration is in the range of 25 to 100 (μg / mL medium). The higher the value, the higher the suppression force, but 150 (μg / mL medium) is somewhat inferior to 100 (μg / mL medium). It was found that the amount of melanin produced was suppressed from vitamin C at any concentration. However, there was almost no difference between the unfermented moon peach and the fermented moon peach (moon peach tea).
[Reference Example 2]

(細胞内におけるチロシナーゼ活性の測定)
細胞内におけるチロシナーゼ活性及びタンパク質量を測定し、タンパク質当たりの酵素活性を求めた。
(1)測定試料の調製:参考例1と同様の方法により培地に所定濃度のサンプルを添加し、B16メラノーマ細胞を培養した。培地を除去し、PBS(−)溶液で細胞表面を2回洗浄し、その後0.5%DOC(デオキシコルチコステロン)1mLを加え、細胞をセルスクレイバーで集め、ソニケーターで破砕した。これを遠心分離(11000rpm、20min、4℃)し、その上清部を酵素溶液とした。
(2)チロシナーゼ活性測定:37℃で10分間プレインキュベートした0.05%L−ドーパ(L−DOPA)/0.1M リン酸緩衝溶液1mLに、前記酵素溶液0.5mLを加え、37℃でインキュベートしながら475nmの吸光度を経時的(1min)に10分間測定した。
L−ドーパ(L−DOPA)の自動酸化を測定するために、同時に、0.05%L−ドーパ/0.1M リン酸緩衝溶液1mLに0.5%DOC0.5mLを加えたものの吸光度も経時的に測定し、ベースラインとした。横軸に反応時間(min)、縦軸にタンパク質当たりの測定開始からのO.D.475nmの変化量をとったグラフから、その反応開始後の傾きを求め、チロシナーゼ活性とした。コントロールにおけるチロシナーゼ活性を100%として、各濃度で比較した。
(3)タンパク質量定量(Lowry法)
試薬A:2%NaCO−in0.1N NaOH
試薬B:0.5%CuSO・5HO−1%酒石酸カリウムまたはナトリウム
試薬C:試薬A/試薬B=50/1に混合。毎回新調
試薬D:フェノール試薬(市販品を使用時に蒸留水で2倍に希釈する)
タンパク質標準溶液:アルブミン標品約5mg/10mL。正確に秤量する。
[操作]0.2mL中にタンパク質5〜100μgを含むサンプル溶液を試験管に取り、試薬Cを1mL添加、混合する。室温で10分間以上放置した後、試薬D0.2mLを加え、すばやく混合する。20分以上2時間以内に吸光度750nmで比色を行う。検量線は標準アルブミン溶液を希釈して、30〜200μg/mL用いて作成した。
(Measurement of intracellular tyrosinase activity)
The tyrosinase activity and protein amount in the cells were measured, and the enzyme activity per protein was determined.
(1) Preparation of measurement sample: A sample of a predetermined concentration was added to the medium by the same method as in Reference Example 1, and B16 melanoma cells were cultured. The medium was removed, and the cell surface was washed twice with PBS (−) solution. Then, 1 mL of 0.5% DOC (deoxycorticosterone) was added, and the cells were collected with a cell scraper and disrupted with a sonicator. This was centrifuged (11000 rpm, 20 min, 4 ° C.), and the supernatant was used as an enzyme solution.
(2) Tyrosinase activity measurement: 0.5 mL of the enzyme solution was added to 1 mL of 0.05% L-DOPA (L-DOPA) /0.1 M phosphate buffer solution preincubated for 10 minutes at 37 ° C. Absorbance at 475 nm was measured over time (1 min) for 10 minutes with incubation.
In order to measure auto-oxidation of L-DOPA (L-DOPA), the absorbance of 0.5 mL DOC added to 1 mL of 0.05% L-DOPA / 0.1 M phosphate buffer solution was also measured over time. Measured to be a baseline. Reaction time (min) on the horizontal axis and O.D. from the start of measurement per protein on the vertical axis. D. The slope after the start of the reaction was determined from the graph with the amount of change at 475 nm, and was defined as tyrosinase activity. Comparison was made at each concentration with the tyrosinase activity in the control as 100%.
(3) Protein amount quantification (Lowry method)
Reagent A: 2% Na 2 CO 3 -in0.1N NaOH
Reagent B: 0.5% CuSO 4 .5H 2 O-1% potassium or sodium tartrate Reagent C: Reagent A / Reagent B = 50/1 mixed. Every time new reagent D: phenol reagent (diluted with distilled water twice when using a commercial product)
Protein standard solution: Albumin preparation about 5 mg / 10 mL. Weigh accurately.
[Operation] A sample solution containing 5 to 100 μg of protein in 0.2 mL is taken into a test tube, and 1 mL of reagent C is added and mixed. After standing at room temperature for 10 minutes or more, add 0.2 mL of reagent D and mix quickly. Colorimetry is performed at an absorbance of 750 nm within 20 minutes to 2 hours. A calibration curve was prepared by diluting a standard albumin solution and using 30 to 200 μg / mL.

無醗酵の月桃と醗酵させた月桃(月桃茶)の濃度を、0(コントロール)、25、50、100,150(μg/mL medium)としたものと、ビタミンC(比較例)を50(μg/mL medium)を用いた場合のB16メラノーマのメラニン生成量に及ぼす影響(効果)を前記(2)、(3)のチロシナーゼ活性測定、蛋白質定量の方法を採用して行った。結果を図9に示す。図9より、対照に比べて、無醗酵の月桃と醗酵させた月桃(月桃茶)何れもチロシナーゼ活性は、共に濃度依存的に抑制しており、また、ビタミンCに比べてもチロシナーゼ活性を抑えていることがわかった。しかし、無醗酵の月桃と醗酵させた月桃(月桃茶)の間にはほとんど差が見出せなかったばかりか、100,150(μg/mL medium)では、無醗酵の月桃の方が醗酵月桃よりもチロシナーゼ抑制効果が優れていることがわかった。   Concentrations of non-fermented moon peach and fermented moon peach (moon peach tea) were 0 (control), 25, 50, 100, 150 (μg / mL medium) and vitamin C (comparative example) The effect (effect) exerted on the amount of melanin produced by B16 melanoma when 50 (μg / mL medium) was used was determined by employing the methods for measuring tyrosinase activity and protein quantification described in (2) and (3) above. The results are shown in FIG. FIG. 9 shows that the tyrosinase activity of both the non-fermented moon peach and the fermented moon peach (moon peach tea) is suppressed in a concentration-dependent manner compared to the control, and tyrosinase compared to vitamin C. It was found that the activity was suppressed. However, there was almost no difference between the non-fermented moon peach and the fermented moon peach (moon peach tea). At 100,150 (μg / mL medium), the non-fermented moon peach is more fermented. It was found that the tyrosinase inhibitory effect is superior to moon peach.

(皮膚線維芽細胞増殖促進錠剤の調製)
実施例1における発酵月桃熱水抽出物の凍結乾燥物20.47重量%、コラーゲンペプチド(ゼライズ(株)社製)75.0重量%、ヒアルロン酸0.15重量%((株)ホルス社製)、シリマリン(株式会社常盤植物化学研究所社製)0.5重量%の割合で混合し、粒状の錠剤を得た。
(Preparation of dermal fibroblast growth-promoting tablet)
Lyophilized 20.47% by weight of fermented moon peach hot water extract in Example 1, 75.0% by weight of collagen peptide (manufactured by Zelize Co., Ltd.), 0.15% by weight of hyaluronic acid (Horus Co., Ltd.) Manufactured) and silymarin (manufactured by Tokiwa Plant Chemical Research Co., Ltd.) at a ratio of 0.5% by weight to obtain granular tablets.

(皮膚線維芽細胞増殖促進剤を含有するスキンケア飲食品の調製)
実施例1における発酵月桃熱水抽出物の凍結乾燥物100mgを50mLの水に添加し、ジュース原料のクエン酸、香料、ビタミンC、ブドウ糖、砂糖、異性化糖などを適宜添加し、混合撹拌して、ジュースを得た。
(Preparation of skin care food and drink containing skin fibroblast growth promoter)
100 mg of the freeze-dried fermented moon peach extract in Example 1 is added to 50 mL of water, and citric acid, flavor, vitamin C, glucose, sugar, isomerized sugar, etc., are added as appropriate, and mixed and stirred. And got the juice.

(皮膚線維芽細胞増殖促進剤を含有するスキンケア化粧料の調製)
実施例1における発酵月桃の熱水抽出エキス(発酵月桃エキス)、精製水、グリセリン、及び尿素を下記のような配合にて混合し、スキンケア化粧料を得た。
精製水 93%
グリセリン 3%
尿素 3%
発酵月桃エキス 1%
(Preparation of skin care cosmetics containing skin fibroblast growth promoter)
A hot water extract of fermented moon peach (fermented moon peach extract), purified water, glycerin, and urea in Example 1 were mixed in the following composition to obtain a skin care cosmetic.
Purified water 93%
Glycerin 3%
Urea 3%
Fermented moon peach extract 1%

本発明(醗酵月桃)の熱水抽出液を用いた皮膚線維芽細胞増殖測定結果をコントロール(無添加)、月桃(無醗酵)と共に示す図である。It is a figure which shows the skin fibroblast proliferation measurement result using the hot-water extract of this invention (fermented moon peach) with control (no addition) and moon peach (no fermentation). 本発明(醗酵月桃)の80%エタノール抽出凍結乾燥物を用いた皮膚線維芽細胞増殖測定結果をコントロール(無添加)、月桃(無醗酵)と共に示す図である。It is a figure which shows the dermal fibroblast proliferation measurement result using the 80% ethanol extraction freeze-dried material of this invention (fermented moon peach) with control (no addition) and moon peach (no fermentation). 本発明(発酵月桃粒)服用のエリスマ(赤み)(頬)個人別データを示す図である。It is a figure which shows the individual data of the erythema (redness) (cheek) taking this invention (fermented moon peach grain). 本発明(発酵月桃粒)服用のエリスマ(赤み)の平均値を示す図である。It is a figure which shows the average value of the erythema (redness) taking this invention (fermented moon peach grain). 本発明(発酵月桃粒)服用の弾力(頬)の波形モデルを示す図である。It is a figure which shows the waveform model of the elasticity (cheek) of taking this invention (fermented moon peach grain). 本発明(発酵月桃粒)服用の弾力個人別データを示す図である。It is a figure which shows the data according to elasticity individual for taking this invention (fermented moon peach grain). 本発明(発酵月桃粒)服用の弾力についての平均値を示す図である。It is a figure which shows the average value about the elasticity of taking this invention (fermented moon peach grain). 本発明(無醗酵月桃、醗酵月桃)のメラニン生成抑制効果をコントロール(無添加)、とビタミンCと共に示す図である。It is a figure which shows the melanin production inhibitory effect of this invention (non-fermented moon peach, fermented moon peach) with control (no addition) and vitamin C. 本発明(無醗酵月桃、醗酵月桃)のチロシナーゼ活性の抑制効果をコントロール(無添加)、とビタミンCと共に示す図である。It is a figure which shows the inhibitory effect of the tyrosinase activity of this invention (no fermented moon peach, fermented moon peach) with a control (no addition) and vitamin C.

Claims (8)

月桃を乳酸菌、乳酸菌と酵母、乳酸菌と枯草菌、又は乳酸菌と酵母と枯草菌により発酵させて得られる発酵処理物を有効成分とすることを特徴とする皮膚線維芽細胞増殖促進剤。 A skin fibroblast growth promoter characterized by comprising as an active ingredient a fermented product obtained by fermenting moon peach with lactic acid bacteria, lactic acid bacteria and yeast, lactic acid bacteria and Bacillus subtilis, or lactic acid bacteria and yeast and Bacillus subtilis. 発酵処理物が、月桃の葉の発酵処理物であることを特徴とする請求項1記載の皮膚線維芽細胞増殖促進剤。 The dermal fibroblast growth promoter according to claim 1, wherein the fermented product is a fermented product of moon peach leaves. ラクトバシルス・プランタリム、ストレプトコッカス・サーモフィルス、バシルス・ズブチルスの混合菌による発酵処理物であることを特徴とする請求項1又は2記載の皮膚線維芽細胞増殖促進剤。 The dermal fibroblast proliferation promoter according to claim 1 or 2, which is a fermented product of a mixed bacterium of Lactobacillus plantarim, Streptococcus thermophilus, and Bacillus subtilis. 発酵処理物が、抽出エキス又はその凍結乾燥物であることを特徴とする請求項1〜3のいずれか記載の皮膚線維芽細胞増殖促進剤。 The dermal fibroblast growth promoter according to any one of claims 1 to 3, wherein the fermented product is an extract or a lyophilized product thereof. 請求項1〜4のいずれか記載の皮膚線維芽細胞増殖促進剤を含有することを特徴とするスキンケア飲食品。 A skin care food or drink comprising the dermal fibroblast proliferation promoter according to any one of claims 1 to 4. さらに、シリマリン(Silymarin)、コラーゲンペプチド、及びヒアルロン酸から選ばれる1種以上の成分を含有することを特徴とする請求項5記載のスキンケア飲食品。 Furthermore, the skin care food-drinks of Claim 5 containing the 1 or more types of component chosen from silymarin (Silymarin), a collagen peptide, and hyaluronic acid. 請求項1〜4のいずれか記載の皮膚線維芽細胞増殖促進剤を含有することを特徴とするスキンケア化粧料。 A skin care cosmetic comprising the dermal fibroblast growth promoter according to any one of claims 1 to 4. さらに、シリマリン(Silymarin)、コラーゲンペプチド、及びヒアルロン酸から選ばれる1種以上の成分を含有することを特徴とする請求項7記載のスキンケア化粧料。 The skin care cosmetic according to claim 7, further comprising at least one component selected from silymarin, collagen peptide, and hyaluronic acid.
JP2005287782A 2005-09-30 2005-09-30 Skin fibroblast proliferation promoter Expired - Fee Related JP4942322B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2005287782A JP4942322B2 (en) 2005-09-30 2005-09-30 Skin fibroblast proliferation promoter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005287782A JP4942322B2 (en) 2005-09-30 2005-09-30 Skin fibroblast proliferation promoter

Publications (2)

Publication Number Publication Date
JP2007099625A true JP2007099625A (en) 2007-04-19
JP4942322B2 JP4942322B2 (en) 2012-05-30

Family

ID=38026912

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005287782A Expired - Fee Related JP4942322B2 (en) 2005-09-30 2005-09-30 Skin fibroblast proliferation promoter

Country Status (1)

Country Link
JP (1) JP4942322B2 (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242261A (en) * 2008-03-28 2009-10-22 Maruzen Pharmaceut Co Ltd Anti-inflammatory agent, anti obesity agent, and skin care preparation, foodstuff and beverage
JP2009242263A (en) * 2008-03-28 2009-10-22 Maruzen Pharmaceut Co Ltd Anti-aging agent, and skin care preparation, foodstuff and beverage
JP2010178736A (en) * 2009-01-06 2010-08-19 Zenyaku Kogyo Kk Skin beauty-ameliorating agent, antioxidant, skin beauty-ameliorating composition, or cosmetic food/drink
WO2013060771A3 (en) * 2011-10-25 2014-01-30 Arch Personal Care Products, L.P. Composition containing an extract of a sequential or simultaneous fermentation
JP2014125467A (en) * 2012-12-27 2014-07-07 Nippon Shinyaku Co Ltd Fibroblast growth promoter
CN104705756A (en) * 2015-02-12 2015-06-17 青岛食安生物工程有限公司 Beneficial bacterium collagen beverage
WO2018155660A1 (en) * 2017-02-24 2018-08-30 Rapas株式会社 Composition containing dead cell bodies of lactic acid bacterium or treated product thereof, and cosmetic, household good, drug or food containing said composition
CN112402333A (en) * 2019-08-22 2021-02-26 伽蓝(集团)股份有限公司 Application of red rice fermentation extract in preparation of cosmetics
CN112891283A (en) * 2021-02-01 2021-06-04 浙江万里学院 Dendrobium officinale fermentation extract, skin care product and preparation method thereof
CN113116760A (en) * 2021-05-21 2021-07-16 广州市万千粉丝化妆品有限公司 Skin collagen proliferation promoter containing yeast flora
CN115337238A (en) * 2022-08-24 2022-11-15 广州环亚化妆品科技股份有限公司 Preparation method and application of coffee fermented product

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001316275A (en) * 1999-10-18 2001-11-13 Maruzen Pharmaceut Co Ltd Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic, food and drink
JP2002003390A (en) * 2000-06-26 2002-01-09 Maruzen Pharmaceut Co Ltd Fibroblast growth agent, food and drink for beauty culture and skin cosmetic
JP2002034505A (en) * 2000-07-19 2002-02-05 Sunstar Inc Food composition formulated with silymarin
JP2002186457A (en) * 2000-12-22 2002-07-02 Toyo Shinyaku:Kk Health food for beauty, containing kale processed product
JP2002330725A (en) * 2001-03-07 2002-11-19 Ryukyu Bio Resource Kaihatsu:Kk Fermented food material, method for producing the same, drink or food, and extract
JP2003055244A (en) * 2001-08-06 2003-02-26 Maruzen Pharmaceut Co Ltd Agent promoting hyaluronic acid production, cosmetics, food and beverage including the hyaluronic acid production-promoting agent
WO2004085429A1 (en) * 2003-03-25 2004-10-07 Fancl Corporation Composition for promoting production of type i collagen and/or elastin
JP2005053863A (en) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk Prophylactic and therapeutic agent for diabetes mellitus disease
JP2005211078A (en) * 2005-04-01 2005-08-11 Yaizu Suisankagaku Industry Co Ltd Beauty and health food

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001316275A (en) * 1999-10-18 2001-11-13 Maruzen Pharmaceut Co Ltd Collagen production promoter, estrogen-like agent, collagenase inhibitor, skin cosmetic, food and drink
JP2002003390A (en) * 2000-06-26 2002-01-09 Maruzen Pharmaceut Co Ltd Fibroblast growth agent, food and drink for beauty culture and skin cosmetic
JP2002034505A (en) * 2000-07-19 2002-02-05 Sunstar Inc Food composition formulated with silymarin
JP2002186457A (en) * 2000-12-22 2002-07-02 Toyo Shinyaku:Kk Health food for beauty, containing kale processed product
JP2002330725A (en) * 2001-03-07 2002-11-19 Ryukyu Bio Resource Kaihatsu:Kk Fermented food material, method for producing the same, drink or food, and extract
JP2003055244A (en) * 2001-08-06 2003-02-26 Maruzen Pharmaceut Co Ltd Agent promoting hyaluronic acid production, cosmetics, food and beverage including the hyaluronic acid production-promoting agent
WO2004085429A1 (en) * 2003-03-25 2004-10-07 Fancl Corporation Composition for promoting production of type i collagen and/or elastin
JP2005053863A (en) * 2003-08-06 2005-03-03 Ryukyu Bio Resource Kaihatsu:Kk Prophylactic and therapeutic agent for diabetes mellitus disease
JP2005211078A (en) * 2005-04-01 2005-08-11 Yaizu Suisankagaku Industry Co Ltd Beauty and health food

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009242261A (en) * 2008-03-28 2009-10-22 Maruzen Pharmaceut Co Ltd Anti-inflammatory agent, anti obesity agent, and skin care preparation, foodstuff and beverage
JP2009242263A (en) * 2008-03-28 2009-10-22 Maruzen Pharmaceut Co Ltd Anti-aging agent, and skin care preparation, foodstuff and beverage
JP2010178736A (en) * 2009-01-06 2010-08-19 Zenyaku Kogyo Kk Skin beauty-ameliorating agent, antioxidant, skin beauty-ameliorating composition, or cosmetic food/drink
US10272121B2 (en) 2011-10-25 2019-04-30 Arch Personal Care Product, Lp Composition containing an extract of a sequential or simultaneous fermentation
JP2014530890A (en) * 2011-10-25 2014-11-20 アーチ・パーソナル・ケアー・プロダクツ・リミテッド・パートナーシップ Compositions containing extracts of continuous or simultaneous fermentation
WO2013060771A3 (en) * 2011-10-25 2014-01-30 Arch Personal Care Products, L.P. Composition containing an extract of a sequential or simultaneous fermentation
JP2014125467A (en) * 2012-12-27 2014-07-07 Nippon Shinyaku Co Ltd Fibroblast growth promoter
CN104705756A (en) * 2015-02-12 2015-06-17 青岛食安生物工程有限公司 Beneficial bacterium collagen beverage
CN104705756B (en) * 2015-02-12 2016-08-24 青岛食安生物工程有限公司 Probiotics collagen beverage
WO2018155660A1 (en) * 2017-02-24 2018-08-30 Rapas株式会社 Composition containing dead cell bodies of lactic acid bacterium or treated product thereof, and cosmetic, household good, drug or food containing said composition
CN112402333A (en) * 2019-08-22 2021-02-26 伽蓝(集团)股份有限公司 Application of red rice fermentation extract in preparation of cosmetics
CN112891283A (en) * 2021-02-01 2021-06-04 浙江万里学院 Dendrobium officinale fermentation extract, skin care product and preparation method thereof
CN113116760A (en) * 2021-05-21 2021-07-16 广州市万千粉丝化妆品有限公司 Skin collagen proliferation promoter containing yeast flora
CN115337238A (en) * 2022-08-24 2022-11-15 广州环亚化妆品科技股份有限公司 Preparation method and application of coffee fermented product
CN115337238B (en) * 2022-08-24 2023-09-05 广州环亚化妆品科技股份有限公司 Preparation method and application of coffee ferment

Also Published As

Publication number Publication date
JP4942322B2 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
JP4942322B2 (en) Skin fibroblast proliferation promoter
TWI381834B (en) Abnormal protein removal composition
JP4205188B2 (en) Maillard reaction inhibitor
TWI500428B (en) Sugar-free pineapple extract, method for producing the extract, and application of the extract
JP2021502953A (en) Cosmetic composition for skin whitening and wrinkle improvement containing Centella asiatica extract as an active ingredient
CN111053716A (en) Application of Fuzhuan tea extract in preparation of skin conditioning product
JP2022173481A (en) collagenase inhibitor
KR101295368B1 (en) Composition for skin wrinkle improvement comprising extracts of honeybush extract or its fermentation solution as an active ingredient
KR102355143B1 (en) Method for preparing fermentated ziziphus jujuba seed
JP6055667B2 (en) Collagen production promoter
JP4672269B2 (en) Anti-aging agent, platelet aggregation inhibitor, antioxidant, antiallergic agent, skin cosmetics and food and drink
JP5220346B2 (en) Skin cosmetics
JP2019147824A (en) Kaempferia parviflora-containing compositions
KR102471009B1 (en) Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles
KR100564107B1 (en) Cosmetic composition comprising plant extract having anti-aging effect
KR20170137405A (en) Composition for improving skin condition comprising herb extracts mixture
JP2005029556A (en) Skin aging-preventing agent
TW202102239A (en) Antiaging agent, antioxidant, antiinflammatory agent and whitening agent, and cosmetic
KR20210004155A (en) Composition for improving winkle or skin whitening comprising coreopsis lanceolate l. extract
JP4902967B2 (en) Melanin production inhibitor
KR20200104999A (en) Cosmetic Compositions for Anti-aging Comprising Extracts of Plants
JP2020002053A (en) Collagen production promoter, MMP inhibitor, melanin production inhibitor, cell growth promoter, antioxidant, wrinkle improver, pharmaceutical or food composition
KR102355138B1 (en) Composition for whitening or anti-wrinkle of the skin comprising fermentated ziziphus jujuba seed as effective component
TWI653989B (en) a composition comprising an herbal extract obtained by processing oriental herbs
KR102526200B1 (en) Composition for Skin Moisturizing and Whitening Comprising Decurcinol as Active Ingredient

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080910

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111026

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111129

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20111219

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120116

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120206

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120228

R150 Certificate of patent or registration of utility model

Ref document number: 4942322

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150309

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees